Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Load latest

Lasa Supergenerics Ltd.

08 Apr 2022

18.01

-0.72%

Company Update

Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended March 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita ShettyDesignation :- Company Secretary and Compliance Officer

Lasa Supergenerics Ltd.

07 Apr 2022

18.01

-0.72%

Company Update

Lasa Supergenerics Ltd - 540702 - Clarification On Significant Price Movement

BSE India

This is with reference to communication received from NSE vide email dated April 06, 2022 Ref No.NSE/CM/Surveillance seeking clarification in significant price moment and clarification sought by BSE vide update on corporate announcement section on website for significant movement in the price of the shares of the Company across exchanges. In this regard, we wish to inform you that the Company is in compliance with SEBI (LODR) Regulations, 2015 and has been promptly informing the Stock Exchange on all events and information, which have a bearing on operation or performance of the Company. The upcoming Board meeting which is scheduled to be held on Monday April 11 ,2022 where the Board of Directors may consider the dividend which is disclosed in intimation dated March 21,2022 might be the reason for the price movement.

pdf

Lasa Supergenerics Ltd.

06 Apr 2022

18.01

-0.72%

Company Update

Lasa Supergenerics Ltd - 540702 - Clarification sought from Lasa Supergenerics Ltd

BSE India

The Exchange has sought clarification from Lasa Supergenerics Ltd on April 6, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Lasa Supergenerics Ltd.

05 Apr 2022

18.01

-0.72%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation …

BSE India

This is to certify that in compliance with regulation 7(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, all activities in relation to share transfer facility are maintained by our Share Transfer Agent i.e. Bigshare Services Private Limited having permanent SEBI Registration No INR0000001385. This certificate for the year ended 31st March 2022 is issued in compliance with Regulation 7(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

pdf

Lasa Supergenerics Ltd.

21 Mar 2022

18.01

-0.72%

SAST

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

BSE India

In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct, the Trading Window shall continue to remain closed from March 21, 2022 till 48 hours after the declaration of the Audited financial results of the Company for the quarter and year ended March 31, 2022.

pdf

Lasa Supergenerics Ltd.

21 Mar 2022

18.01

-0.72%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Consideration Of Audited Financials And To …

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/04/2022 ,inter alia, to consider and approve 1. To consider, approve and take on records Audited financial results of the Company for the quarter and year ended March 31, 2022. 2. To consider and recommend the dividend for the financial year ended March 31, 2022, subject to the approval of the shareholders at the ensuing General Meeting of the Company. 3. To discuss any other matter with the permission of the Chairperson.

pdf

Lasa Supergenerics Ltd.

15 Feb 2022

18.01

-0.72%

SAST

Lasa Supergenerics Ltd - 540702 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 15, 2022 for Omkar Pravin Herlekar

pdf

Lasa Supergenerics Ltd.

07 Feb 2022

18.01

-0.72%

Result

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which commenced at 02.00 p.m. and concluded at 3.30 p.m. inter- alia has considered and approved the following: 1. The statement of un-audited financial result for the quarter and nine months ended December 31, 2021. 2. Limited review Report from Statutory Auditor for the quarter ended December 31, 2021.

pdf

Lasa Supergenerics Ltd.

04 Feb 2022

18.01

-0.72%

SAST

Lasa Supergenerics Ltd - 540702 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 04, 2022 for Omkar Pravin Herlekar

pdf

Lasa Supergenerics Ltd.

04 Feb 2022

18.01

-0.72%

SAST

Lasa Supergenerics Ltd - 540702 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Omkar Pravin Herlekar

pdf

Is Lasa Supergenerics Ltd. worth buying?

50 Votes:

Buy 76.0%

Sell 18.0%

Hold 6.0%